Holen Sie sich die Stockscreener-App
10.62
0.00%
0.00
Handel nachbörslich:
10.62
Schlusskurs vom Vortag:
$10.62
Offen:
$10.63
24-Stunden-Volumen:
1,161
Relative Volume:
0.01
Marktkapitalisierung:
$257.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$6.66M
KGV:
53.58
EPS:
0.1982
Netto-Cashflow:
$-379.20K
1W Leistung:
+0.14%
1M Leistung:
+0.33%
6M Leistung:
+2.51%
1J Leistung:
+4.22%
1-Tages-Spanne:
$10.62
$10.63
1-Wochen-Bereich:
$10.61
$10.63
52-Wochen-Spanne:
$10.17
$10.63
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Firmenname
Drugs Made In America Acquisition Corp
Sektor
Branche
Telefon
646-726-7074
Adresse
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, DMII, BCSS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.62 | 257.82M | 0 | 6.66M | -379.20K | 0.1982 |
LION
Lionsgate Studios Corp
|
15.35 | 4.18B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.64 | 2.11B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
24.45 | 1.18B | 17.25M | -5.64M | -40.16M | -0.3337 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.10 | 642.10M | 0 | 8.58M | -1.11M | 0.134 |
BCSS
Bain Capital Gss Investment Corp
|
10.21 | 596.26M | 0 | 8.29M | -686.50K | 0.142 |
Drugs Made In America Acquisition Corp Aktie (DMAA) Neueste Nachrichten
DMAAR Rights Trade Flat Near All-Time Low as Investors Await Merger CatalystBearish Pattern Stocks - newsline.com
DMAA Hovers Near $10.62 as SPAC Consolidates Ahead of Potential CatalystFair Value Gap - newsline.com
US Retreat from Global Leadership Stirs Uncertainty Across AsiaFinancial Health Score - newsline.com
Drugs Made In America Acquisition II Corp. Right (DMIIR) Holds Flat at $0.08 as Rights Trading Remains DormantDip Buy Trade - newsline.com
DMII Holds Steady at $10.08: SPAC Trading in a Narrow RangeTICK Divergence - newsline.com
DMIIU Holds Steady at $10.12 as SPAC Unit Trades in Tight RangeFear Greed Extreme - newsline.com
DMIIR Rights Trading Slumps 9.09% to $0.08 – Micro-Cap Struggles for DirectionReversal Setup Alerts - newsline.com
SUNE Q2 2024 Earnings: EPS Surges Past Estimates Despite Heavy Losses; Stock Plummets 27%Fiscal Year Earnings - newsline.com
Grove Collaborative (GROV) Edges Higher as Shares Approach Resistance ZoneSMA Signal - newsline.com
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIR - TradingView
GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover - Reuters
Brand Engagement Network Inc. (BNAI) Q3 2025 Earnings: Narrowed Loss Surprises as Pre-Revenue Company Gains MomentumEarnings Growth Forecast - newsline.com
Broadcom, Micron, ARM Lead Chip Stock Decline After Disappointing Broadcom EarningsHigh Estimate Range - newsline.com
Free float of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
QDRO Acquisition Corp.: Performance & Quotes, QADR Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue - Investing.com
Drugs Made In America Acquisition Corp. Rights (DMAAR) Edge Higher Amid Low-Price SpeculationVolume Climax - newsline.com
DeFi Development Corp. Warrant (DFDVW) Testing Support After 3.85% DeclineRatio Spread Trade - thelegaladvocate.com
VTAK Q1 2025 Earnings: Significant EPS Miss Amid Operational ChallengesEarnings Call Transcript - newsline.com
Shalibhadra Finance Targets Rs 500 Crore AUM on 22% Profit Growth in FY26Net Income Trends - thelegaladvocate.com
SQM Q2 2025 Earnings: Lithium Miner Posts $0.31 EPS as Shares Rise 2.17% Amid Market UncertaintyEarnings Weakness Phase - lwvtexas.org
Drugs Made In America Acquisition II Corp. Right (DMIIR) Drops 10% as Rights Trade Near Support at $0.08Volatility Breakout Picks - The Legal Advocate
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Amid Extended ConsolidationVolatility Smirk - The Legal Advocate
Drugs Made In America Acquisition Corp. Rights (DMAAR) Slides 7.4% – Testing Key Support ZoneRip Sell Trade - newsline.com
NXRT Q1 2026 Earnings: Narrower-Than-Expected Loss, Stock Edges LowerBanking Earnings Report - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. Right (DMIIR) Moves Up 8.91% at $0.09 – Right Securities See Renewed InterestGamma Squeeze - The Legal Advocate
Harvard Ave Acquisition (HAVA) Stock Holds Steady at $10.08 as Trading Remains FlatZero Lag EMA - The Legal Advocate
NXGL Q1 2026 Earnings: Larger-Than-Expected Loss Weighs on SharesEarnings Manipulation Risk - thelegaladvocate.com
Evolution Global Acquisition Corp Warrants (EVOXW) Surge 18.6% as Price Approaches Key ResistanceChaikin Flow - The Legal Advocate
DMII Holds Steady at $10.07 as SPAC Shares Track Trust ValueETF NAV Deviation - newsline.com
Eli Lilly and Company - Britannica
DMIIU Units Edge Lower by 0.44% as Price Holds Near $10.11 Amid Quiet TradingVWAP Breakout - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Steady Near Trust Value Amid Low VolatilityInstitutional Sentiment - The Legal Advocate
DMIIR Rights Hover at $0.09 as Flat Trading Persists for Drugs Made In America Acquisition II Corp.Social Sentiment - The Legal Advocate
Huadi International Group (HUDI) Faces Steep Decline, Testing Key Support at $1.0Turnaround Stocks - thelegaladvocate.com
Drugs Made In America Acquisition II Corp. (DMII) Holds Steady Near Resistance: A Detailed AnalysisAdaptive Moving Average - The Legal Advocate
Drugs Made In America Acquisition Corp. Rights (DMAAR) Edges Higher: Analyzing the $0.12 LevelLiquidity Order Flow - newsline.com
SAGU_u|SAGU_u.NB|Price:10.090|Chg%:0.04 - TradingKey
PTACU|Patriot Acquisition Units (Proposed)|Price:9.950|Chg%:-0.01 - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
MMCAP International Inc. SPC's Drugs Made In America Acquisition II Corp(DMII) Holding History - GuruFocus
BioLife Solutions (BLFS) Faces Headwinds: Shares Decline 3.19% to $23.95ADD Alert - newsline.com
Trump-Xi Summit: The 3 Big Takeaways from Historic Meeting in BeijingReturn On Equity - The Legal Advocate
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
BofA (BAC) Q1 2026 Earnings: $1.11 EPS Surges Past $1.02 EstimatesAdjusted Earnings Analysis - newsline.com
TradingKey - TradingKey
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition II Corp(DMIIU) Holding History - GuruFocus
Shutterstock, Inc. 8-K Filing: UK CMA Approves Merger with Getty Images Holdings, Inc - Minichart
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
GUACU|Berto Acquisition II Units (Proposed)|Price:10.030|Chg%:-0.01 - TradingKey
DMAA Price Today: Drugs Made In America Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC
Finanzdaten der Drugs Made In America Acquisition Corp-Aktie (DMAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.10%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):